In silico Evaluation of Natural chalcones as Aromatase and EGFR Tyrosine Kinase inhibitors to Combat Breast and Ovarian Cancers. (2025). Vascular and Endovascular Review, 8(9s), 120-131. https://verjournal.com/index.php/ver/article/view/729